{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:05:43Z","timestamp":1785423943579,"version":"3.56.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jdiacomp.2022.108227","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T12:26:10Z","timestamp":1654691170000},"page":"108227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of dronedarone on patients with atrial fibrillation and diabetes: A sub-analysis of the ATHENA and EURIDIS\/ADONIS studies"],"prefix":"10.1016","volume":"36","author":[{"given":"Yehuda","family":"Handelsman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Jared","family":"Bunch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena W.","family":"Rodbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munveer","family":"Thind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Bigot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana","family":"Konigsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Wieloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Kowey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2022.108227_bb0010","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCULATIONAHA.114.014796","article-title":"Impact of diabetes mellitus on hospitalization for heart failure, cardiovascular events, and death: outcomes at 4 years from the reduction of atherothrombosis for continued health (REACH) registry","volume":"132","author":"Cavender","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0015","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1161\/CIRCULATIONAHA.118.034986","article-title":"Incidence of hospitalization for heart failure and case-fatality among 3.25 million people with and without diabetes mellitus","volume":"138","author":"McAllister","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0020","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/jamacardio.2016.5224","article-title":"Atrial fibrillation, type 2 diabetes, and non\u2013vitamin K antagonist oral anticoagulants: a review","volume":"2","author":"Plitt","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.amjcard.2011.03.004","article-title":"Meta-analysis of cohort and case\u2013control studies of type 2 diabetes mellitus and risk of atrial fibrillation","volume":"108","author":"Huxley","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0030","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007351","article-title":"Atrial fibrillation and diabetes mellitus: can we modify stroke risk through glycemic control?","volume":"12","author":"Ugowe","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0035","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fphys.2019.00135","article-title":"The association between diabetes mellitus and atrial fibrillation: clinical and mechanistic insights","volume":"10","author":"Bohne","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0040","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/STROKEAHA.115.009371","article-title":"Duration of diabetes mellitus and risk of thromboembolism and bleeding in atrial fibrillation: nationwide cohort study","volume":"46","author":"Overvad","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41569-018-0080-2","article-title":"Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs","volume":"16","author":"Patti","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.15420\/usc.2016:1:1","article-title":"Identification of patients at risk of stroke from atrial fibrillation","volume":"10","author":"Fohtung","year":"2016","journal-title":"US Cardiol Rev"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0055","article-title":"Atrial fibrillation management in 2021: an updated comparison of the current CCS\/CHRS, ESC, and AHA\/ACC\/HRS guidelines","author":"Cheung","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0060","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMoa0803778","article-title":"Effect of dronedarone on cardiovascular events in atrial fibrillation","volume":"360","author":"Hohnloser","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0065","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1161\/CIRCULATIONAHA.109.875252","volume":"120","author":"Connolly","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0070","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa054686","article-title":"Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter","volume":"357","author":"Singh","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0075","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/europace\/euq450","article-title":"Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation","volume":"13","author":"Freemantle","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0080","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1213\/01.ane.0000229709.29185.88","article-title":"Diabetes mellitus reduces the antiarrhythmic effect of ion channel blockers","volume":"103","author":"Ito","year":"2006","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0085","first-page":"290","article-title":"Effect of amiodarone on the pharmacodynamics of gliclazide in animal models","volume":"5","author":"Gadiko","year":"2013","journal-title":"Int J Pharm Pharm Sci"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0090","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1517\/17425255.2012.722619","article-title":"CYP2C metabolism of oral antidiabetic drugs-impact on pharmacokinetics, drug interactions and pharmacogenetic aspects","volume":"8","author":"Holstein","year":"2012","journal-title":"Expert Opin Drug Metabol Toxicol"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0095","first-page":"30","article-title":"A study on effect of amiodarone on the pharmacokinetic of repaglinide in diabetic animal","volume":"12","author":"Khedkar","year":"2021","journal-title":"Adv Biores"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0100","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/pds.5034","article-title":"Risk of severe hypoglycemic events from amiodarone-sulfonylureas interactions: a population-based nested case-control study","volume":"29","author":"Lai","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0105","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/bmj.288.6413.285","article-title":"Can amiodarone induce hyperglycaemia and hypertriglyceridaemia?","volume":"288","author":"Politi","year":"1984","journal-title":"Br Med J (Clinical Res Ed)"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1540-8167.2007.01016.x","volume":"19","author":"Hohnloser","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0115","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/01.CIR.65.3.457","article-title":"Clinical classification of cardiac deaths","volume":"65","author":"Hinkle","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0120","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/CIRCULATIONAHA.108.829176","article-title":"Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham heart study, 1950 to 2005","volume":"119","author":"Preis","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0125","first-page":"677","article-title":"Undiagnosed type 2 diabetes mellitus and its risk factors among malaysians: national health and morbidity survey, 2011","volume":"6","author":"Ismail","year":"2016","journal-title":"Int J Public Health Res"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-019-0953-7","article-title":"Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study","volume":"18","author":"Lee","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0135","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.121.056323","article-title":"Early rhythm control therapy in patients with atrial fibrillation and heart failure","volume":"144","author":"Rillig","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0140","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/europace\/euv214","article-title":"Catheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and meta-analysis","volume":"17","author":"Anselmino","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0145","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1540-8167.2010.01786.x","article-title":"Long-term outcome of atrial fibrillation ablation: impact and predictors of very late recurrence","volume":"21","author":"Wokhlu","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0150","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.amjcard.2010.07.038","article-title":"Atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation associated with diabetes mellitus or impaired fasting glucose","volume":"106","author":"Chao","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0155","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jacc.2013.02.091","article-title":"Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients","volume":"62","author":"Marfella","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0160","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2337\/diacare.28.3.668","article-title":"Diabetes, glucose, insulin, and heart rate variability: the atherosclerosis risk in communities (ARIC) study","volume":"28","author":"Schroeder","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0165","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/clc.22667","article-title":"Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact","volume":"40","author":"Dilaveris","year":"2017","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0170","article-title":"Subclinical atrial fibrillation and stroke: insights from continuous monitoring by implanted cardiac electronic devices","volume":"17","author":"Lau","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0175","article-title":"Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial","author":"Willems","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.2487","article-title":"Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial","author":"Vaduganathan","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0185","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.002832","article-title":"Resting heart rate and the risk of microvascular complications in patients with type 2 diabetes mellitus","volume":"1","author":"Hillis","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0190","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pcad.2009.05.005","article-title":"Elevated heart rate in cardiovascular diseases: a target for treatment?","volume":"52","author":"Palatini","year":"2009","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0195","first-page":"81","article-title":"Diabetes and acute coronary syndrome","volume":"101","author":"Keller","year":"2010","journal-title":"Minerva Med"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0200","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12933-019-0927-9","article-title":"Disease-treatment interactions in the management of patients with obesity and diabetes who have atrial fibrillation: the potential mediating influence of epicardial adipose tissue","volume":"18","author":"Packer","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.2519","article-title":"Dronedarone in the treatment of atrial fibrillation with concomitant heart failure and preserved or mildly reduced ejection fraction: closer to Ithaca after a long Odyssey?","author":"Boriani","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0210","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"January","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0215","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2022.108227_bb0220","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872722001337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872722001337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:15:17Z","timestamp":1761005717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872722001337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1056872722001337"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108227","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of dronedarone on patients with atrial fibrillation and diabetes: A sub-analysis of the ATHENA and EURIDIS\/ADONIS studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108227","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"108227"}}